A phase 1b study to assess the safety, tolerability, and clinical activity of bgb-290 in combination with temozolomide (TMZ) in subjects with locally advanced or metastatic solid tumors
2017-001553-14Tumores sólidos avanzados y/o metastásicosFundación Jiménez DíazInvestigador: Moreno García Víctor